Proven track record of developing and manufacturing spray-dried dispersions to overcome poor drug solubility and delivery challenges.
Poor solubility compounds are highly prevalent in the industry pipeline presenting a major challenge for dosage-form selection. Pharmaceutical spray drying is an established formulation technique at Quotient Clinical, tailored towards the physical and chemical properties of each molecule. Providing GMP manufacturing capabilities at the 100mg to 3kg scale, we have advanced more than 20 spray dried dispersion (SDD) formulations into clinical studies in the last 2 years.
In a typical program of work we will:
Capabilities and applications include:
Quotient Clinical recently expanded its GMP processing capabilities with a larger scale Niro Mobile Minor™ Spray Dryer (read more), and a partnership with spray-drying specialists Upperton Ltd (read more).